Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

79
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
79
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

46
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
46
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

597
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
597
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

68
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
68
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

104
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
104
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

60
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
60

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Uncertainty Quantification in Molecular Machine Learning for Property Predictions under Data Shifts.

Journal of chemical information and modeling·2026
Same author

Practically Significant Method Comparison Protocols for Machine Learning in Small Molecule Drug Discovery.

Journal of chemical information and modeling·2025
Same author

Estimation of In Vivo Half-Life From In Vitro Metabolic Clearance, Protein, and Cell Membrane Affinity Assays.

ChemMedChem·2025
Same author

The changing landscape of medicinal chemistry optimization.

Nature reviews. Drug discovery·2025
Same author

Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 Inflammasome.

Journal of medicinal chemistry·2024
Same journal

Development of [<sup>111</sup>In]In-CHX-A″-DTPA-αCD68 for ImmunoSPECT to Image Murine Macrophages.

Molecular pharmaceutics·2026
Same journal

Mechanistic Insight into Self-Gelation Involved in Prescription Design for Optimization of Tablet Performance.

Molecular pharmaceutics·2026
Same journal

[<sup>68</sup>Ga]Ga-DOTA-DP-UBI 29-41: A Novel <sup>68</sup>Ga-Labeled Ubiquicidin 29-41 Derivative Containing d-Proline for Bacterial Infection PET Imaging.

Molecular pharmaceutics·2026
Same journal

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA.

Molecular pharmaceutics·2026
Same journal

Preclinical Evaluation of <sup>177</sup>Lu-Labeled Anti-CLDN18.2 VHH-Fc for Radioimmunotherapy in Gastric Cancer.

Molecular pharmaceutics·2026
Same journal

The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films.

Molecular pharmaceutics·2026
查看所有相关文章

相关实验视频

Updated: Jun 8, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

DeepCt:使用深度学习从化学结构预测药物动力学度-时间曲线和分区模型.

Maximilian Beckers1, Dimitar Yonchev1, Sandrine Desrayaud1

  • 1Biomedical Research, Novartis Pharma AG, Novartis Campus, 4002 Basel, Switzerland.

Molecular pharmaceutics
|November 6, 2024
PubMed
概括
此摘要是机器生成的。

DeepCt是一种新的深度学习方法,可以从分子结构中预测药物度-时间概况. 这种方法通过估计药理动力学参数和减少动物试验,有助于早期药物开发.

关键词:
分区分析是分区分析.度 - 时间.深度学习是一种深度学习.发现药物的发现.机器学习是机器学习.机械模型模型机械模型药物动力学 药物动力学时间暴露时间暴露

更多相关视频

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.9K

相关实验视频

Last Updated: Jun 8, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.9K

科学领域:

  • 药理学和药物开发领域
  • 计算化学计算化学
  • 机器学习在生命科学中的应用

背景情况:

  • 在临床前药物开发中的药物动力学 (PK) 研究评估了哺乳动物随时间推移的药物度.
  • 度-时间 (C-t) 档案对于导出PK参数至关重要,指导分子选择.
  • 目前的机器学习工作往往预测PK参数,而不是C-t配置文件本身,限制了机械洞察力.

研究的目的:

  • 介绍DeepCt,一种新的深度学习方法,用于直接从复合结构中预测C-t配置文件.
  • 为了能够预测底层的机理性药理动力学模型.
  • 为了促进单剂量和多剂量CT特征的模拟和预测.

主要方法:

  • 开发一个深度学习模型 (DeepCt) 用于C-t概况预测.
  • 整合机械分区药理动力学建模原理.
  • 从化学化合物结构中预测C-t曲线的应用.

主要成果:

  • DeepCt成功地从复合结构中预测了C-t形状.
  • 该方法允许预测潜在的机械 PK 模型.
  • 能够对各种剂量场景进行模拟和预测.

结论:

  • DeepCt提供了一种新的深度学习解决方案,用于预测药物C-t概况.
  • 这种方法可以通过改善PK预测和减少动物研究来增强早期药物发现.
  • 机械模型方面为ADME流程提供了更深入的见解.